Aims: Apoptosis regulatory proteins, such as p53, play a pivotal role in neural differentiation, through mechanisms independent of cell death. In addition, p53 has been identified as an important regulator of mitochondrial survival response, maintaining mitochondrial DNA (mtDNA) integrity and oxidative protection. The aim of this study was to determine the role of mitochondrial p53 in organelle damage and neural differentiation. Results: Our results show that mitochondrial apoptotic events such as reactive oxygen species production, mitochondrial membrane permeabilization, and cytochrome c release are typical of early-stage mouse neural stem cell differentiation, which occurs 3-18 h after induction of differentiation, with no evidence of cell death. In addition, decreased mtDNA content, lipidated LC3 (LC3-II), colocalization of mitochondria and LC3-II puncta, and mitochondria-associated Parkin are consistent with activation of mitophagy. Importantly, at early stages of neural differentiation, p53 was actively translocated to mitochondria and attenuated mitochondrial oxidative stress, cytochrome c release, and mitophagy. Forced mitochondrial translocation of p53 increased neurogenic potential and neurite outgrowth. Innovation and Conclusion: In conclusion, our results reveal a novel role for mitochondrial p53, which modulates mitochondrial damage and apoptosis-related events in the context of neural differentiation, thus enhancing neuronal fate. Antioxid. Redox Signal. 21, 1009-1024.
Introduction
P oor survival and differentiation of neural stem cells (NSCs) have been a major problem for efficient use in neural replacement therapy. Therefore, a better understanding of the basic molecular mechanisms of long-term survival and differentiation of stem cells represents a step toward novel potential therapeutic approaches. Others and we have recently demonstrated that conserved elements of apoptosis, including p53, caspases, calpains, and apoptosis-associated microRNAs participate in neural differentiation, through mechanisms independent of cell death (3, 16, 18, 50, 53, 68) . Thus, essential players of apoptosis executioner pathways may have a dual function in differentiation and cell death; they cannot be totally blocked to assure differentiation efficiency, but must be carefully regulated to avoid cell loss.
Recent evidence has suggested that mitochondria may also affect the proliferative and differentiation potential of Innovation Conserved executioners of the apoptosis machinery, namely p53, have been shown to participate in neural differentiation through mechanisms independent of cell death. In addition, p53 has been identified as a key regulator of the mitochondrial survival response under stress conditions. Identifying the mechanisms by which mitochondrial p53 impacts on neural stem cell survival after differentiationelicited mitochondrial damage is essential for a better understanding of how essential players of apoptosis may play a dual function in cell fate decision. stem cells (2, 43, 47) . In fact, the density and activity of mitochondria vary in several types of terminally differentiated cells due to distinct levels of energy demand. The undifferentiated stage is usually associated with mitochondrial low oxygen consumption, needed to maintain the proliferative capacity (15) , while aerobic metabolism, in association with increased reactive oxygen species (ROS) production, is crucial for successful differentiation (28, 62) . Indeed, in response to changes of the cellular environment, such as those of differentiation, mitochondria may become a major producer of ROS and release prodeath proteins, rapidly changing into a death-promoting organelle. Curiously, the release of cytochrome c has also been associated with vital cell functions, including differentiation, suggesting that it does not always occur in an all-or-nothing fashion (20) . A novel role for cytochrome c has also been described in remodeling chromatin at the nucleus compartment (38) .
Surprisingly, in skeletal muscle and fibroblasts, p53 has been shown to mediate several nonapoptotic mitochondrial changes, including mitochondria aerobic metabolism (19, 33, 42) , maintenance of mitochondrial DNA (mtDNA) stability, and oxidative protection (1, 29) . Regulation of cellular function by p53 may occur through transcription-dependent and -independent mechanisms at the mitochondria, involving modulation of mitochondrial ROS production (23) . Mitochondrial oxidative stress is thought to trigger mitophagy, a selective type of autophagy characterized by the engulfment of dysfunctional mitochondria in a multimembrane structure, the autophagosome, delivery, and subsequent degradation by the cells own lysosomal system (17, 56) . In fact, autophagy plays multifunctional roles in cellular adaptation to stress, by maintaining mitochondrial integrity. Since ROS are required for this selective autophagic process, it is tempting to speculate that p53 mayregulatemitochondrialqualitycontrolmechanisms,suchas mitophagy, and differentiation-related oxidative damage.
In this study, we sought to investigate the role of mitochondrial p53 during NSC differentiation. We demonstrate that mitochondrial apoptosis-associated events, including mitochondrial membrane depolarization, ROS production, and cytochrome c release, as well as mitophagy are typical of earlystage mouse NSC differentiation. In contrast, active mitochondrial translocation of p53 prevented differentiationinduced mitochondrial alterations and enhanced neural fate, suggesting a novel role for p53-dependent mitochondrial control of NSC differentiation.
Results

Mitochondrial apoptosis-associated events in neural differentiation
Recent evidence suggests that mitochondrial apoptosisassociated events affect the proliferative and differentiation potential of NSCs (54) . However, the precise mechanism by which differentiating cells can block preactivated apoptosis during differentiation is still unknown. To further understand mitochondrial alterations during neural differentiation, we used a NSC line. Induction of differentiation resulted in a tripotential cell population, favoring the conversion into the neuronal lineage compared with astroglial or oligodendroglial lineages (45, 52) . In the present study, cells were allowed to differentiate up to 6 days and the expression of stemness (nestin), neuronal (bIII-tubulin), glial (GFAP), and oligo-dendrial (NG2) markers was analyzed throughout time by flow cytometry analysis. As expected, our results showed that under proliferative conditions, the majority of cells are positive for the proliferative marker nestin, and less than 3% are positive for bIII-tubulin, GFAP, or NG2. In addition, decreased proportions of nestin-positive cells and markedly increased bIII-tubulin-positive cells were observed in differentiating cells ( p < 0.01). Under these conditions, only few of the cells became GFAP-and NG2-positive at 1 and 6 days of differentiation ( p < 0.01), thus indicating that these in vitro differentiation conditions efficiently bias NSCs toward the neuronal lineage ( Fig. 1A) .
More importantly, mitochondrial membrane depolarized throughout neural differentiation, as assessed by a significant decrease in DiOC 6 (3) mitochondrial incorporation ( p < 0.01) ( Fig. 1B ). Cells were also incubated with the MitoSOXÔ Red reagent, which is oxidized by superoxide and exhibits red fluorescence, hence allowing the detection and quantification of mitochondrial ROS. Curiously, mitochondrial ROS levels were transiently increased at 1 h of differentiation, significantly decreasing at 6 and 18 h ( p < 0.01) and returning to basal levels thereafter (Fig. 1C ). Moreover, NSC pretreatment with the cell-permeant 2¢,7¢-dichlorodihydrofluorescein diacetate (H 2 DCFDA) also revealed a similar trend in total intracellular ROS levels (data not shown). Since ROStriggered mitochondrial membrane depolarization often results in mitochondrial cytochrome c release, the cellular distribution of cytochrome c was also evaluated throughout NSC differentiation. Notably, a transient but marked decrease of mitochondrial cytochrome c ( p < 0.01) was accompanied by a transient increase of cytosolic cytochrome c ( p < 0.01) ( Fig. 1D ). The relative purity of mitochondrial and cytosolic extracts was controlled using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and voltage-dependent anion channel (VDAC) antibodies, respectively. In addition, to investigate whether differentiation-induced cytochrome c releaseresultsinincreasedcelldeath,cellviabilitywasassessedby the Guava ViaCount assay and by measuring Annexin-V-and propidium iodide (PI)-negative cells by flow cytometry analysis ( Supplementary Fig. S1A ; Supplementary Data are available online at www.liebertpub.com/ars). No significant alterations, using both methods, were detected in cell death or cell viability during early-stage NSC differentiation. These findings indicate that neural differentiation induces mitochondrial apoptosisassociated events, which in turn do not involve cell death per se.
Mitophagy activation in neural differentiation
To further investigate the mechanisms by which differentiating cells block preactivated apoptosis during neural differentiation, we explored the presence of mitophagy, the major degradation pathway involved in mitochondrial quality control. In fact, recent studies have demonstrated that oxidative stress normally causes activation of mitochondrial quality control mechanisms leading to subsequent degradation of damaged mitochondria by mitophagy. The mtDNA content was quantified during neural differentiation by real-time polymerase chain reaction (PCR). Interestingly, the mtDNA copy number significantly decreased throughout NSC differentiation ( p < 0.01) ( Fig. 2A ). To better understand whether the decrease of the mitochondrial population was correlated to activation of mitophagy as a neural differentiation-induced mechanism of mitochondrial quality control, we assessed the conversion of endogenous LC3-I/-II as well as the mitochondrial translocation of Parkin. Recent studies have correlated the mitochondrial translocation of the cytosolic E3 ubiquitin ligase, Parkin, to the complete removal of depolarized and damaged mitochondria by mediating a quality control pathway of mitophagy (5, 37, 47, 56) . The lipidated LC3 autophagic marker ( Fig. 2B ) and mitochondrial Parkin (Fig. 2C ) increased after 6 h of neural differentiation ( p < 0.01), as assessed by immunoblotting analysis. The occurrence of mitophagy in this cellular context was confirmed by immunocytochemistry analysis, using confocal microscopy, where colocalization of LC3-II puncta and mitochondria was easily detected at 18 h of differentiation ( Fig. 2D ). Finally, the autophagic flux was controlled using 3-methyladenine (3-MA), an early phase inhibitor of autophagy that blocks autophagosome formation, and bafilomycin A 1, a late phase inhibitor of autophagy that prevents the fusion between autophagosomes and lysosomes. As expected, at 18 h of differentiation, a significant decrease or accumulation in lipidated LC3 form was observed in 3-MA-and bafilomycin A 1 -treated NSCs, respectively ( p < 0.01). Immunocytochemistry analysis using confocal microscopy corroborated immunoblotting data ( Fig. 2E ). These results indicate that mitophagy may occur as a survival mechanism by which differentiating cells induce the clearance of damaged mitochondria and block preactivated mitochondrial apoptosis. The tumor suppressor p53 protein has recently been identified as a critical regulator of mitochondrial survival response in several cell types, as it mediates mtDNA integrity and oxidative protection (1, 19, 23) . Surprisingly, immunoblot analysis showed that p53 is actively but transiently translocated to mitochondria as early as 3 h after induction of neural differentiation ( p < 0.01), returning to basal levels after 2 days of differentiation induction (Fig. 3A) . The rela-tive purity of mitochondrial fractionation was controlled using the Lamin B1 antibody, which indicated the absence of nuclear contamination in the mitochondrial extracts. In addition, colocalization of p53 and mitochondria was easily monitored by confocal microscopy in NSCs, after 6 h of differentiation ( Fig. 3B ).
We then addressed the impact of p53 mitochondrial relocation on differentiation-induced oxidative stress, cytochrome c release, and mitophagy, by modulating p53 mitochondrial translocation in differentiating NSCs, rather than using a p53 null system that would also influence p53 nuclear function (53) . For that, cells were transfected with the To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars overexpressing plasmids, RECQL4-Wt and RECQL4-D84, which cannot translocate to the mitochondria, and RECQL4-GST, unable to physically interact with p53 ( Fig. 4A) (13) . The latter serves as a control to understand whether the effects are dependent on p53 or RECQL4 mitochondrial translocation. RECQL4, a nuclear protein member of the conserved RecQ family of DNA helicases (49) , has been recently shown to physically interact with p53 to prevent its function as a transcription factor in the nucleus, and facilitate p53 mitochondrial localization (13) . In accordance with p53 mitochondrial relocation, an increase of mitochondrial RECQL4 expression was observed at 3 and 6 h of NSC differentiation, markedly decreasing thereafter (at least p < 0.05) ( Supplementary Fig. S2 ). Higher levels of mitochondrial p53 were detected at 6 h of neural differentiation in RECQL4-Wttransfected cells when compared with control (mock) ( p < 0.01), while p53 mitochondrial translocation significantly decreased in RECQL4-D84-and RECQL4-GSTtransfected cells, when compared with wild type ( p < 0.01) ( Fig. 4B) . These results were also corroborated by immuno-cytochemistry analysis at 18 h of neural differentiation, using confocal microscopy ( Fig. 4C ). More importantly, modulation of p53 mitochondrial translocation during NSC differentiation revealed that forced mitochondrial relocation of p53 results in a marked decrease in oxidative stress at 6 h, also observed at later time points of neural differentiation (Fig.  5A ). In addition, enhanced mitochondrial levels of p53 resulted in further retention of cytochrome c at the mitochondrial compartment at 6 h of differentiation induction (Fig.  5B ). In fact, mitochondrial ROS (at least p < 0.01) and cytosolic cytochrome c levels ( p < 0.05) were strongly diminished in RECQL4-Wt-transfected cells when compared with control or RECQL4-mutant-transfected cells. Curiously, when p53 was forced to translocate to mitochondria, the mtDNA copy number increased ( p < 0.05) ( Fig. 6A ) and both LC3-II ( p < 0.01) ( Fig. 6B ) and mitochondria-associated Parkin (Fig. 6C ) decreased (at least p < 0.05), when compared with mock or RECQL4-mutant-transfected cells. This suggests that regulation of mitochondrial damage by mitochondrial p53 is sufficient to increase the mitochondrial number and rule out the need for mitophagy activation. These results were further confirmed by decreased colocalization of LC3-II puncta and mitochondria, at 18 h of differentiation, in RECQL4-Wt-transfected cells when compared with control or RECQL4-mutant-transfected cells, using confocal microscopy. However, at 48 h of neural differentiation, the impact of mitochondrial p53 modulation, on these events, seems to be attenuated ( Fig. 6D ). Thus, our results reveal a novel role for mitochondrial p53, abrogating mitochondrial damage and preventing apoptosis-related events throughout neural differentiation.
p53 modulation of mitochondrial stress in neural differentiation is dependent on mitochondrial MnSOD activation Superoxide dismutases (SOD) are the most commonly known scavengers of mitochondrial ROS in the cell (23) . Although p53 has a protective effect on mitochondrial oxidative stress by regulating manganese superoxide dismutase (MnSOD) expression through the nucleus (23, 41) , recent evidence suggests that mitochondrial p53 plays a role, along with MnSOD, in preventing mtDNA damage (1, 6, 7, 22, 32) . Thus, we determined if the molecular mechanisms by which p53 prevents mitochondrial alterations during NSC differentiation are dependent on MnSOD. Interestingly, immunoblot analysis showed that MnSOD mitochondrial levels transiently increased at 3 and 6 h after induction of NSC differentiation ( p < 0.01), returning to basal levels after this time ( Fig. 7A ). More importantly, modulation of p53 mitochondrial translocation during NSC differentiation revealed that forced mitochondrial relocation of p53 markedly increased MnSOD mitochondrial levels at 6 h of differentiation, when compared with its levels in control or RECQL4mutant-transfected cells ( p < 0.01) ( Fig. 7B ). Our results also showed that the effect of mitochondrial p53 in increasing mitochondrial levels of MnSOD may result, in part, from the ability of mitochondrial p53 to promote a more efficient import of this SOD, as demonstrated by a significant decrease of MnSOD cytosolic levels after forced mitochondrial translocation of p53 ( p < 0.01) (Fig. 7B ). The effect of mitochondrial p53 on MnSOD protein stability was also Our results demonstrated that MnSOD was reduced in < 3 h, in control and RECQL4-mutant-transfected cells ( p < 0.05). In contrast, MnSOD protein levels did not decrease until 6 h in RECQL4-Wt-transfected NSCs, demonstrating that p53 mitochondrial translocation also regulates the stability of MnSOD (Fig. 7C ).
Finally, to understand whether MnSOD was involved in mitochondrial p53 regulation of differentiation-induced mitochondrial ROS levels, we treated NSCs with cyclosporin A (CsA), a chemical inhibitor of mitochondrial MnSOD, and reevaluated mitochondrial oxidative stress. Surprisingly, CsA markedly induced mitochondrial ROS levels throughout neural differentiation ( p < 0.01) ( Fig. 7D ). More importantly, CsA-induced inhibition of MnSOD abolished the effect of mitochondrial p53 in modulating mitochondrial ROS lev-els ( p < 0.01) ( Fig. 7E ). Thus, our results reveal that p53mediated mitochondrial oxidative protection during NSC differentiation is dependent on MnSOD activation.
p53 mitochondrial translocation enhances neuronal fate
To further investigate the precise role of mitochondrial p53 during neural fate, the impact of p53 mitochondrial translocation on NSC viability and differentiation was determined. Although modulation of p53 mitochondrial translocation did not elicit profound changes in cell death and viability throughout NSC differentiation ( Supplementary Fig. S1B ), the percentage of nestin-and bIII-tubulin-positive cells significantly decreased and increased, respectively, in RECQL4-Wttransfected cells, when compared with mock or RECQL4 mutant plasmids (at least p < 0.05), (Fig. 8A ). We did not observe any changes in the percentage of GFAP-and NG2positive cells in RECQL4-Wt-transfected cells, when To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ ars compared with mock or RECQL4 mutant plasmids (data not shown). The proneurogenic effects of mitochondrial p53 were corroborated by immunocytochemistry analysis (Fig. 8B ). In fact, in NSCs undergoing differentiation, forced mitochondrial p53 relocation promoted neuronal morphology, including neurite elongation and branching. The total neurite output, longest length, and number of neurites per cell were 45, 50, and 55% increased, respectively, after 1 day of neural differentiation when compared with mock or RECQL4 mutant plasmids ( p < 0.01). Interestingly, longer term studies revealed that the effect of mitochondrial p53 manipulation in enhancing neuronal fate remains detectable at 48 h of NSC differentiation (Fig. 8C ). The changes elicited by forced p53 mitochondrial relocation on nestin and bIII-tubulin expression, as well as on the total neurite output and longest neurite length, were more evident after 6 days, when compared with 1 day of NSC differentiation. These results demonstrate that mitochondrial translocation of p53 strongly impacts on the neurogenic potential and on neurite elongation and branching of NSCs, with no changes on the survival rate.
Discussion
Apoptosis regulatory events may be involved in nonapoptotic functions, including differentiation, cell cycle progression, inflammation, metabolism, and autophagy (18, 53) . However, the molecular checkpoints responsible for differentiation, as an alternative to cell death, remain poorly understood, despite the potential for therapeutic development. In this study, we suggest a novel role for mitochondrial p53 at early stages of neural differentiation. Our results indicate that mitochondrial translocation of p53 abrogates differentiation-induced mitochondrial alterations, including mitochondrial membrane depolarization, oxidative stress, and mitophagy, thus enhancing neuronal fate.
Mitochondria influence a wide range of cellular processes by mechanisms defined as retrograde signaling (9, 27) . Indeed, the integrity and functional stage of mitochondria are crucial for cell proliferation, differentiation, apoptosis, and survival (34, 36, 43) . During neural differentiation, profound mitochondrial morphologic and metabolic alterations occur to assure successful differentiation (26, 28, 40, 59, 62) . On the other hand, the transition from anaerobic to aerobic metabolism implicates oxygen consumption, increased oxidative stress, and mitochondrial damage. In the present study, we have explored mitochondrial apoptosis-associated alterations during neural differentiation and showed that mitochondrial membrane depolarization and transient ROS production accompanied the neurogenic process. In fact, during the first 3 h of differentiation, neither p53 nor MnSOD has been sufficiently increased at the mitochondrial compartment to avoid mitochondrial stress. We believe that the subsequent decrease in mitochondrial ROS might be due to mitochondrial translocation of p53 and significant increases in MnSOD mitochondrial levels, which occur later during the differentiation process. Our data are in accordance with other studies highlighting the importance of mitochondrial dynamics and oxidative stress during routine neurogenesis (28, 62) . In fact, a group of oxidation responsive genes was recently correlated to antioxidant administration, and was significantly elevated in genetic-and exercise-induced models of hyperactive hippocampal neurogenesis (61) . Indeed, due to their ability to directly interact with specific receptors and to redox activate protein kinases and phosphatases, and transcription factors (51) , controlled levels of ROS were shown to be pivotal as specific second messengers of signaling pathways involved in cell proliferation and differentiation. In addition, while mitochondrial fusion and fission are involved in regulating mitochondrial integrity during differentiation (34, 43, 66) , they may also contribute to mitochondrial membrane depolarization, oxidative stress, and apoptosis (64) . In agreement with neurogenesis-induced mitochondrial membrane permeabilization, we showed a transient release of cytochrome c from mitochondria during NSC differentiation. Nevertheless, increased ROS, mitochondrial membrane depolarization, and cytochrome c release did not enhance NSC death. Of note, in an apoptotic context, released cytochrome c was shown to gradually (38) . Therefore, it is not surprising that neurogenesisassociated cytochrome c release may also be involved in chromatin remodeling required for the differentiation process. On the other hand, recent unpublished studies (Deshmukh M., personal communication) revealed that Hsp70 interacts with released cytochrome c to mediate its ubiquitination, thus preventing mitochondria-mediated cell death. Thus, it is also possible that Hsp70 might contribute for cell death resistance and neuronal survival in this cellular context. An increase in total levels of Hsp70 was also observed throughout NSC differentiation (data not shown). Nevertheless, additional mechanisms must be in place in differentiating cells to block preactivated apoptosis and avoid cell loss, which may involve p53-induced mitochondrial survival and mitophagy. Our results showed an increase of mitophagy throughout neural differentiation, as determined by increased lipidated LC3 and mitochondrial Parkin, colocalization of LC3-II puncta and mitochondria, as well as decreased mtDNA content. A decreased mitochondrial population may result from differentiation-induced engulfment of mitochondrial organelles through activation of mitophagy (25, 56) , while Parkin translocation to the outer mitochondrial membrane of depolarized mitochondria is thought to ubiquitylate and recruit proteins that initiate this mechanism (10, 17, 25, 30, 65) , ultimately ensuring mitochondrial quality control. Interestingly, autophagy has been shown to play a critical role in stem cell maintenance and in a variety of cell differentiation processes (4, 58, 67) , also fulfilling NSC high-energy demands (57) .
In the recent past, the proapoptotic protein p53 has been ascribed with an ever-increasing number of cellular functions, including the proneurogenic effect and mitochondrial survival response. The proneurogenic role of p53 is not entirely understood, but appears to be related with cell fate determination, actin cytoskeleton regulation, and control of specific signaling pathways (54) . p53 has also been shown to regulate the cellular redox status by activating either anti-or pro-oxidant factors (19) . In response to oxidative damage, p53 is translocated to mitochondria and physically interacts with mtDNA polymerase c (Polc), thereby promoting mtDNA replication and repair (1, 6, 22) . Importantly, others have also demonstrated that p53 null mouse and p53 knockdown human primary fibroblasts exhibit mtDNA depletion and loss of mtDNA copy number under normal culture conditions (29) . Based on the function of p53 and mitochondria during stem cell differentiation (31, 53, 68) as well as on the above evidence, we investigated the role of p53 in neurogenesis-induced mitochondrial alterations. Our results revealed that, following induction of NSC differentiation, p53 is actively translocated to mitochondria. More importantly, modulation of p53 mitochondrial relocation significantly altered differentiation-induced mitochondrial membrane depolarization, cytochrome c release, and oxidative stress, as well as the levels of mitophagy. Since mitochondrial changes only occur at early stages of neural differentiation, the manipulation of mitochondrial p53 did not promote major effects on mitochondria-associated events at later stages of differentiation. Our data support the idea that mitochondrial p53 is able to trigger a mitochondrial survival response and prevent apoptosis-associated events, under the early neural differentiation context. An exhaustive investigation on p53 submitochondrial distribution in different cell contexts would certainly help to further understand the variety of p53 roles in modulating mitochondrial apoptosis events. In fact, the localization of p53 at the surface of mitochondria is sufficient to induce apoptosis (39, 60, 63) . In contrast, when p53 is localized to other mitochondrial compartments such as the mitochondrial matrix, it maintains mitochondrial genome integrity (1) . In fact, while the antioxidant function of nonmitochondrial p53 has been well described (8, 11, 23, 24, 48) , its antioxidative effect on the mitochondrial compartment has not been completely elucidated. Therefore, we further investigated the molecular mechanisms by which p53 prevents mitochondrial oxidative protection during NSC differentiation. Interestingly, our results support a functional coupling between the regulation of MnSOD, the major scavenger of mitochondrial ROS, and the decrease of mitochondrial damage by mitochondrial p53. In fact, although a negative regulation of MnSOD by mitochondrial p53 has already been demonstrated (23, 41) , p53 may also play a role, along with MnSOD, in preventing mtDNA damage (7) . The presence of mitochondrial p53 was shown to enhance the accuracy and repair efficiency of mtDNA by Polc (1, 6, 22) . On the other hand, mitochondrial MnSOD may also interact with Polc to protect it from peroxynitrite-mediated inactivation (7, 32) . Thus, it is possible that NSCs might use this novel step strategy to counteract differentiation-induced mitochondrial damage involving p53, MnSOD, and Polc. In fact, our results also demonstrated that mitochondrial relocation of p53 promotes a more efficient mitochondrial import of MnSOD and its protein stabilization during the neural differentiation context, thus implicating p53, along with MnSOD, in preventing differentiation-induced oxidative stress. In fact, inhibition of MnSOD resulted in increased mitochondrial ROS levels, even after forced p53 mitochondrial translocation. This hypothesis is in agreement with our results demonstrating an increase in mtDNA content and reduction of mitophagy after forced mitochondrial p53 relocation. On the other hand, although mitophagy may be regulated by p53 (8, 35) , it has never been directly associated with p53 mitochondrial relocation. The inhibition of neural differentiation-elicited mtDNA decrease and mitophagy that we observed in RECQL4-Wt-transfected cells might be partially explained by an indirect effect of mitochondrial p53 in regulating ROS and mtDNA damage. In fact, it appears that mitophagy acts downstream of p53 mitochondrial protection to avoid cell death. Forced mitochondrial localization of p53 during differentiation, by using RECQL4-Wt plasmids, enhanced mitochondrial integrity, as shown by increased mtDNA content and reduced mitochondrial ROS. Therefore, the activation of mitophagy, as a backup protection mechanism, decreases when compared with normal differentiating conditions. This is in accordance with no effect of mitochondrial p53 manipulation in cell viability.
Finally, we show that mitochondrial localization of p53, rather than promoting major effects on cell viability, has a long-term impact on neuronal fate and neurite outgrowth of NSCs. Previous studies showing the protective role of mitochondrial p53 in maintaining mtDNA integrity (1, 23, 42) , and a strong linkage between mtDNA integrity and NSC fate (62) , are also in agreement with the effect of mitochondrial p53 in increasing NSC neuronal fate. Indeed, 8-oxoguanine DNA glycosylase (OGG1) was shown to be pivotal for both mtDNA damage repair and NSC survival, being its expression associated with a higher neurogenic potential, while accumulation of mtDNA damage shifted NSC differentiation toward an astrocytic lineage. Additional experiments are eagerly required to elucidate p53-specific mitochondrial targets during NSC differentiation.
In conclusion, the present study provides a role for mitochondrial p53 in preventing NSC differentiation-elicited mitochondrial damage. In addition to influencing neuronal fate, p53 mitochondrial translocation is critical for the modulation of neuronal morphology, and neurite elongation and branching.
Materials and Methods
Ethics statement
The mouse NSC line used in this study was obtained from Dr. Smith's Laboratory, University of Cambridge, Cambridge, United Kingdom (52), and provided by Dr. Henrique, University of Lisbon, Lisbon, Portugal. The Animal Ethical Committee at the Faculty of Pharmacy, University of Lisbon, Portugal waived the need for approval.
Cell culture
NSCs were derived from 14.5-dpc mouse fetal forebrain. This cell line was established using a method that produces pure cultures of adherent NSCs, which continuously expand by symmetrical division and are capable of tripotential differentiation (12, 21, 44) . NSCs were grown in monolayers as previously described (50, 55) and routinely maintained in an undifferentiation medium, comprising the Euromed-N medium (ECM0883L; EuroClone S.p.A., Pavia, Italy), supplemented with 1% N-2 supplement (17502-048; InvitrogenÔ, Life Technologies Corporation, Carlsbad, CA), 20 ng/ml epidermal growth factor (EGF, 315-09; PeproTech EC, London, United Kingdom), 20 ng/ml basic fibroblast growth factor (bFGF, 100-18B; PeproTech EC), and 1% penicillinstreptomycin (15140-122; Invitrogen, Life Technologies Corp.), in uncoated tissue culture plastic flasks at 37°C in a humidified atmosphere of 5% CO 2 . The medium was changed every 3 days and cells collected with accutase (A11105-01; Sigma-Aldrich Corporation, St. Louis, MO) when confluent. Neural differentiation was performed by first platting NSCs in the undifferentiation medium onto uncoated tissue culture plastic dishes at 6.5 · 10 5 cells/ml for 24 h, and changing the culture medium to a differentiation medium, comprising the Euromed-N medium supplemented with 10 ng/ml bFGF, 0.5% N-2 supplement, 1% B27 supplement (17504-044; Invitrogen, Life Technologies Corp.), and 1% penicillin-streptomycin. Cells were collected at 1, 3, 6, 18, 24, 48 h, and 6 days after induction of differentiation and processed for flow cytometry, immunoblotting, immunofluorescence, and quantitative real-time PCR assays. For autophagic flux control, NSCs were treated with 5 mM 3-MA (M9281; Sigma-Aldrich Corp.) or with 100 nM bafilomycin A 1 (tlrl-baf1; InvivoGen Corporation, San Diego, CA) for 8 h before harvest. To inhibit the activity of MnSOD, NSCs were treated with 10 lM CsA (30024; Sigma-Aldrich Corp.) for 1 h before harvest. CsA induces nitration of MnSOD in tyrosine 34 residues, leading to MnSOD functional inactivation (32, 46) . Finally, to evaluate the effects of mitochondrial p53 in modulating protein stability of MnSOD during differentiation, control and RECQL4-transfected NSCs were untreated (0 h) or treated with 100 lg/ml CHX (C4859; Sigma-Aldrich Corp.), an inhibitor of protein biosynthesis, for 3, 6, and 8 h before harvesting.
Transfection assays
Modulation of p53 mitochondrial translocation was performed by transfecting NSCs with the overexpression plasmids pcDNA3-Flag-RECQL4 (1-1208), pcDNA3-Flag-RECQL4 (D84), and RECQL4-GST, kindly provided by Dr. Sagar Sengupta (13) . pcDNA3-Flag-RECQL4 (1-1208) (RECQL4-Wt) and pcDNA3-Flag-RECQL4 (D84) (RECQL4-D84) were obtained by cloning adenosine-5¢-triphosphate-dependent DNA helicase Q4 (RECQL4) fragments between the NheI and XhoI sites of the FLAG-tagged pcDNA3 construct. The RECQL4-GST construct, in turn, was obtained by cloning the 270-400 fragment of RECQL4 into the EcoR1-XhoI sites of the pGEX4T-1 vector. Twenty-four hours after platting, NSCs were transfected with 5 lg construct per dish, using the LipofectamineÔ 2000 transfection reagent (11668-019; Invitrogen, Life Technologies Corp.), according to the manufacturer's instructions, and 24 h later the medium was changed to the differentiation medium. The efficiency of plasmid transfections was evaluated by monitoring RECQL4 expression in mitochondrial and cytosolic protein extracts by immunoblotting ( Supplementary Fig. S3 ).
Analyses of NSC differentiation
For detection of nestin and bIII-tubulin expression levels, cells were fixed with paraformaldehyde (4%, w/v) in phosphate-buffered saline (PBS) for 20 min at 4°C, washed twice with a washing solution 0.1% saponin (47036; Sigma-Aldrich Corp.) in PBS, and incubated for 20 min in a blocking solution 0.25% saponin and 5% fetal bovine serum (FBS) in PBS. Subsequently, cells were washed and incubated for 30 min with mouse primary antibodies reactive to nestin (MAB353; Merck Millipore Corporation, Billerica, MA), bIII-tubulin (MMS-435P, TUJ1; Covance, Princeton, NJ), GFAP (NCL-GFAP-GA5; Novocastra, ªLeica Microsystems, Wetzlar, Germany), and NG2 (AB5320; Merck Millipore Corp.) at a dilution of 1:300, 1:500, 1:100, and 1:400, respectively. All antibodies were diluted in an antibody blocking solution, 0.1% saponin and 5% FBS in PBS. Cells were then washed twice and incubated with appropriate secondary antibodies, anti-mouse antibodies conjugated to Dylight 649 ( Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) at a dilution of 1:600, and anti-rabbit antibodies conjugated to Alexa Fluor Ò 594 (A-21207; Invitrogen, Life Technologies Corp.) at a dilution of 1:200, for 30 min. Cells were washed twice and resuspended in PBS with 2% FBS and analyzed using LSR FortessaÔ (Becton Dickinson, Mountain View, CA). Data were statistically evaluated using FlowJo software (Tree Star, Inc., Ashland, OR).
Mitochondrial ROS detection
NSCs were washed twice with Ca 2 + -and Mg 2 + -free PBS (Gibco Ò , Life Technologies Corp.), treated with accutase, and harvested with PBS. For mitochondrial ROS quantification, cells were pretreated with 5 lM MitoSOX Red mitochondrial superoxide indicator (M36008; Molecular Probes Ò , Life Technologies Corp.) in Hank's balanced salt solution (HBSS) (24020; Gibco, Life Technologies Corp.) at 37°C for 10 min. Several studies observed that MitoSOX Red reagent is quickly and mostly oxidized by superoxide rather than by other ROS-or reactive nitrogen species-generating systems, and oxidation of the probe is prevented by SOD. The oxidation of the probe becomes highly fluorescent upon binding to nucleic acids. Cells were then resuspended in PBS with 2% FBS (10082147; Invitrogen, Life Technologies Corp.) and emission of red fluorescence was analyzed in intact cells by cytometric analysis using Guava EasyCyte 5HT Ò (Merck Millipore Corp.). Data were statistically evaluated using GuavaSoft Ò software (Merck Millipore Corp.).
Measurement of mitochondrial transmembrane potential
Mitochondrial permeabilization was determined as the retention of the dye 3,3¢-dihexyloxacarbocyanine iodide (DiOC 6 (3), D273; Molecular Probes, Life Technologies Corp.). NSCs were loaded with 50 nM DiOC 6 (3) for 30 min at 37°C and resuspended in PBS with 2% FBS. The emission of green fluorescence was analyzed by fluorescence-activated cell sorting analysis (FACS) using LSR Fortessa (Becton Dickinson). Data were statistically evaluated using FlowJo software (Tree Star, Inc.).
Evaluation of cell death and viability
Viability and cell death levels of NSCs were assessed by performing the ViaCount assay using the Guava easyCyte 5HT Flow cytometer (Guava Technologies, Inc., Merck Millipore Corp.). The ViaCount Assay distinguishes viable and nonviable cells based on differential permeability of two DNA-binding dyes present in the Guava ViaCount Ò Reagent. The nuclear dye only stains nucleated cells, while the viability dye brightly stains dying cells. Briefly, cells were resuspended in 500 ll PBS with 2% FBS. Subsequently, 20 ll of cell suspension was mixed with 180 ll of Guava Via-Count Ò reagent and incubated for 5 min. at room temperature. Sample acquisition and data analysis were performed using the ViaCount software module. Cell death and viability measurements were confirmed by staining NSCs with the Annexin-V-APC apoptosis detection kit (88-8007; eBioscience, Inc., San Diego, CA), according to the manufacturer's instructions. This kit allows the determination of phosphatidylserine exposure as well as the inclusion of the viability dye PI. Samples were analyzed by FACS using LSR Fortessa (Becton Dickinson). Data were statistically evaluated using FlowJo software (Tree Star, Inc.).
Total, mitochondrial, and cytosolic protein extraction
For isolation of total protein extracts, NSCs were collected and lysed using an ice-cold lysis buffer (10 mM Tris-HCl, pH 7.6, 5 mM MgCl 2 , 1.5 mM potassium acetate, 1% Nonidet P-40, 2 mM dithiothreitol) and protease inhibitor cocktail tablets Complete (Roche Applied Science, Mannheim, Germany) for 30 min. Samples were then sonicated, the lysate was centrifuged at 3,200 g at 4°C for 10 min, and the supernatant recovered. For isolation of mitochondrial protein extracts, cells were collected and lysed in an isolation buffer (20 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 .6H 2 O, 1 mM Na 2 EDTA, 1 mM EGTA, 250 mM Sucrose), supplemented with 1 mM DTT and Halt Protease and Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific, Inc., Rockford, IL), for 15 min. Cells were then disrupted by 40 strokes of a glass homogenizer, and homogenates were centrifuged at 2,500 g at 4°C for 10 min. The homogenate recovered was then centrifuged at 12,000 g at 4°C for 30 min to remove unbroken cells and nuclei. The mitochondrial fraction was centrifuged at 12,000 g for 30 min at 4°C, and the pellet resuspended in the isolation buffer and frozen at -80°C. The supernatant was removed and filtered through 0.2-lm and then 0.1-lm Ultrafree MC filters (Merck Millipore Corp.) to give cytosolic proteins. The protein content was measured by the Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA), according to the manufacturer's specifications, using bovine serum albumin as standard.
Immunoblotting
Levels of p53, cytochrome c, LC3, RECQL4, Parkin, and MnSOD were determined by western blot analysis. Briefly, 20-80 lg of total, mitochondrial, and cytosolic proteins were separated on 8%, 12%, or 15% sodium dodecyl sulfatepolyacrylamide electrophoresis gels and then subjected to immunoblotting using primary mouse monoclonal antibodies reactive to p53 (2524; Cell Signaling Technology Ò , Inc., Boston, MA) and cytochrome c (556433; BD Biosciences Pharmingen, San Diego, CA); primary rabbit polyclonal antibodies reactive to LC3 (PA1-16931; Thermo Fisher Scientific, Inc.), Parkin (sc-30130; Santa Cruz Biotechnology, Inc., Dallas, TX), and MnSOD (sc-30080; Santa Cruz Biotechnology, Inc.); or primary goat polyclonal antibodies reactive to mouse RECQL4 (sc-16927; Santa Cruz Biotechnology, Inc.) and human RECQL4 (sc-16924; Santa Cruz Biotechnology, Inc.). Blots were subsequently incubated with secondary antibodies conjugated with anti-mouse and anti-rabbit immunoglobulin G (IgG) conjugated with horseradish peroxidase (Bio-Rad Laboratories) and anti-goat IgG-HRP (sc-2020; Santa Cruz Biotechnology, Inc.) for 2 h at room temperature. Finally, membranes were processed for protein detection using Immobilon (Merck Millipore Corp.) or Super Signal TM substrate (Thermo Fisher Scientific, Inc.). VDAC (4866; Cell Signaling Technology, Inc.), GAPDH (sc-32233; Santa Cruz Biotechnology, Inc.), b-actin (A5441; Sigma-Aldrich Corp.), and Lamin B1 (ab16048; Abcam Ò , Cambridge, United Kingdom) antibodies were used as loading controls and/or to monitor the purity of mitochondrial and cytosolic fractionation.
Quantification of mtDNA copy number
Total cellular DNA was isolated using the QiaAmp DNA Mini Kit (51304; Qiagen, Hilden, Germany), following the manufacturer's protocols. Subsequently, quantitative realtime PCR was performed and a ratio of mtDNA to the nuclear 18S gene was generated for each sample, as previously described (14) . mtDNA and 18S primer sequences used for amplification were as follows: for 18S rDNA nuclear gene 5¢ TAG AGG GAC AAG TGG CGT TC 3¢ (forward) and 5¢ CGC TGA GCC AGT CAG TGT 3¢ (reverse), and for mouse cytochrome oxidase-1 (CO-1) mitochondrial gene 5¢ GCC CCA GAT ATA GCA TTC CC 3¢ (forward) and 5¢ GTT CAT CCT GTT CCT GCT CC 3¢ (reverse). Two independent reactions for each primer set were assessed in a total volume of 25 ll containing 2 · Power SYBR Green PCR master mix and 0.5 lM of each primer. The real-time PCR was run in the ABI 7300 (Applied Biosystems Ò , Life Technologies Corp.) sequence detection system. The relative mtDNA copy number was calculated based on the standard curve and the ratio of the amount of mtDNA versus 18S for each sample. The values were first expressed as percentage of total input and converted to fold change over control.
Immunocytochemistry and confocal microscopy
For visualization of p53 mitochondrial and LC3-II mitochondrial colocalizations in NSCs, cells were incubated with 0.5 lM MitoTracker Ò Red CMXRos (M-7512; Molecular Probes, Life Technologies Corp.), which preferentially accumulates in mitochondria, for 30 min at 37°C before cell harvesting. Cells were washed twice, fixed with paraformaldehyde (4%, w/v) in PBS, and then blocked for 1 h at room temperature in PBS, containing 0.1% Triton-X-100, 1% FBS, and 10% normal donkey serum ( Jackson Im-munoResearch Laboratories, Inc.). Cells were incubated with a primary mouse monoclonal antibody reactive to p53 (2524; Cell Signaling Technology, Inc.) at a dilution of 1:1000 or with a primary rabbit polyclonal antibody reactive to LC3 (PA1-16931; Thermo Fisher Scientific, Inc.) at a dilution of 1:200, overnight at 4°C. After two washes, the secondary DyLight 488-conjugated anti-mouse antibody ( Jackson Im-munoResearch Laboratories, Inc.) diluted 1:100 or the secondary Alexa Fluor 488 (A-21206; Invitrogen, Life Technologies Corp.) diluted 1:200, was added to cells for 2 h at room temperature. For evaluation of NSC differentiation, cells were incubated with the primary mouse monoclonal antibody reactive to bIII-tubulin (MMS-435P, TUJ1; Covance) at a dilution of 1:500 overnight at 4°C. After two washes, the secondary anti-mouse Alexa Fluor 568 (A-10037; Invitrogen, Life Technologies Corp.) was diluted 1:200 and added to cells for 2 h at room temperature. Mouse NSC nuclei were stained with Hoechst 33258 (861405; Sigma-Aldrich Corp.) at 50 lg/ml in PBS, for 3 min at room temperature. Samples were mounted using Fluoromount-GÔ (731604; Beckman Coulter, Inc., Brea, CA). For p53 mitochondrial and LC3-II mitochondrial colocalization, the resulting fluorescent signals were imaged in a multitrack scanning mode using an inverted LSM 510 META confocal laser scanning microscope (Carl Zeiss, Jena, Germany) equipped with a 63x/ 1.4 oil differential interference contrast plan-apochromat objective. Single confocal planes were acquired with an optical slice thickness of 0.8 lm and the images were further processed using ImageJ. NSC differentiation was evaluated using bright field and fluorescence microscopy assessments performed with a Zeiss AX10 microscope (Carl Zeiss, Corp.), equipped with a 63x/1.4 oil plan-apochromat objective and a Leica DFC490 camera (Leica Microsystems). Images were processed using ImageJ.
